Dr Reddy’s Laboratories is expecting to launch over 15 products in the US market in 2018-19. The drug major also remained optimistic for a double digit growth in the domestic market in the ongoing financial year.
The company, which launched three products in the US during March quarter of 2017-18, has over 100 abbreviated new drug applications (ANDAs) lined up for approval with the US Food and Drug Administration (USFDA).
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
